In this review, the key issues that pertain to Waldenström disease are discussed in a concise question-and-answer format. Diagnosis, prognosis, and indications for state-of-the-art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenström Macroglobulinaemia are included.
Keywords: IgM monoclonal proteins; Waldenström macroglobulinaemia; hyperviscosity; lymphoplasmacytic lymphoma; stem cell transplant.
© 2013 John Wiley & Sons Ltd.